MedTrace Logo

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

NCT02849262 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-03-31

No results posted yet for this study

Summary

The purpose of this study is to assess the pharmacodynamics, safety and efficacy of omiganan in patients with external genital warts.

Conditions

  • Condylomata Acuminata (External)

Interventions

DRUG

Omiganan (CLS001) topical gel

DRUG

Vehicle topical gel

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Maruho Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-03-21
Completion
2017-03-21

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02849262 on ClinicalTrials.gov